Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
52.9M
-
Shares change
-
+1.65M
-
Total reported value, excl. options
-
$1.41B
-
Value change
-
+$57.5M
-
Number of buys
-
83
-
Number of sells
-
-71
-
Price
-
$26.59
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2014
168 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2014.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.9M shares
of 115M outstanding shares and own 45.93% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT CO LLP (5.75M shares), VANGUARD GROUP INC (3.69M shares), OAK RIDGE INVESTMENTS LLC (2.65M shares), RS INVESTMENT MANAGEMENT CO LLC (2.41M shares), Bank of New York Mellon Corp (1.82M shares), LORD, ABBETT & CO. LLC (1.68M shares), Champlain Investment Partners, LLC (1.59M shares), BlackRock Institutional Trust Company, N.A. (1.53M shares), BlackRock Fund Advisors (1.51M shares), and Century Capital Management, LLC (1.44M shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.